May 11, 2020 / 11:11 PM / 24 days ago

BRIEF-Endologix Announces Completion Of Enrollment In EVAS2 Confirmatory Clinical Study

May 11 (Reuters) - Endologix Inc:

* ENDOLOGIX ANNOUNCES COMPLETION OF ENROLLMENT IN THE EVAS2 CONFIRMATORY CLINICAL STUDY TO EVALUATE THE NELLIX ENDOVASCULAR ANEURYSM SEALING SYSTEM

* ENDOLOGIX - PLANS TO SUBMIT PMA SHORTLY AFTER FIRST 95 PATIENTS IN TRIAL REACH ONE-YEAR FOLLOW-UP IN MARCH 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below